“BioNTech/Pfizer/(BNT162b2)/COVID-19/MRNA/Vaccine:/Manufacturing,/Immunogenicity,/Efficacy/and/Safety”. 2025. Prospects in Pharmaceutical Sciences 23 (1): 31-46. https://doi.org/10.56782/pps.292.